A blistering battle has broken out between the ALS Association and more than a dozen of its state and local chapters.February 3, 2023Check out STAT+Sponsored By John Blanding/The Boston Globe via AP STAT+ | Leading ALS advocacy group roiled by infighting over money and priorities The ALS Association was accused in a lawsuit by more than a dozen chapters of "catastrophic leadership failures." By Ed Silverman and Andrew Joseph The FTC is finally ready take on health data leaks. The problem is bigger than GoodRx The FTC's action against GoodRx was a first. But with the vast amounts of health data now shared online, it'll be far from the last. By Mohana Ravindranath Opinion: The FDA is the right agency to regulate CBD products, but it needs help The FDA is the best agency to regulate CBD products, but needs new tools to manage CBD risks separate from existing food and supplement rules. By Rosalie Liccardo Pacula Molly Ferguson for STAT STAT+ | They were the 10% left out of life-changing treatments. Now these cystic fibrosis patients may finally get help Vertex and other companies are starting to test treatments that could help the 10 percent of patients who were unaided by "modulator" drugs. By Andrew Joseph Opinion: I was laid off from a public health job. Trust me, tech layoffs are different Layoffs in the tech sector are making headlines. Equally big cuts in the public health workforce have gone almost unnoticed. By Katie D. Schenk More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments